West Pharmaceutical focuses on long term growth, shares steady in S&P 500 healthcare segment
29.06.2026 - 11:30:49 | ad-hoc-news.de
By Stefan Krueger, Long-Term & Business Model desk. Reviewed prior to publication on 2026-06-29, 11:30.
West Pharmaceutical Services (US9523901012) stands out as a specialized healthcare supplier with a long running focus on injectable drug packaging and delivery, and its shares trade on the NYSE as part of the broader S&P 500 health care supplies cohort, according to exchange data and sector classifications.
Where West fits in healthcare
West Pharmaceutical Services positions itself as a key supplier of containment and delivery components for injectable medicines, providing elastomer stoppers, seals and drug delivery systems to biopharma and generic drug manufacturers worldwide, as described on its corporate site and sector profiles.
The company is categorized in the medical and dental supplies industry within the health care sector, and its NYSE listing under ticker WST places it among U.S. large caps that serve as infrastructure providers to pharmaceutical and biotech peers rather than branded drug originators.
Analyst views and profitability debate
Analyst commentary and market analysis have highlighted both West Pharmaceutical Services' strong share price performance and profitability questions, with one review noting that the stock had reached a 52 week high of around 336 dollars earlier in 2026 while simultaneously facing margin pressure concerns based on operating trends and valuation metrics.
These discussions typically point to West's role as a specialized supplier with pricing power in certain product niches, while also tracking cost developments, capital expenditure plans and the competitive landscape in drug packaging and delivery components as key drivers for long term earnings resilience.
All news and analysis on the West Pharmaceutical shares
Further company disclosures, analyst notes and price data on West Pharmaceutical Services are available in the dedicated topic section and via the company’s investor relations page.
How West makes its money
West Pharmaceutical Services generates revenue primarily by supplying containment and delivery components for injectable drugs, including elastomer stoppers, seals, plungers and self injection systems used with vials, syringes and auto injectors in biopharmaceutical and generic medicine applications, according to company materials and sector summaries.
The business model focuses on long term contracts and technical partnerships with drug manufacturers, where West provides high specification components designed to maintain drug stability and facilitate accurate dosing, often supported by regulatory compliant manufacturing facilities and quality assurance frameworks recognized across major healthcare markets.
Where the shares trade today
West Pharmaceutical Services shares (US9523901012) last closed on the NYSE at 351.07 dollars on 2026-06-26, with extended trading data showing 350.73 dollars later that day, according to market price information.
Key data on the West Pharmaceutical shares
- Company: West Pharmaceutical Services, Inc.
- ISIN: US9523901012
- WKN: 851904
- Ticker: WST
- Trading venue: NYSE
- Price (as of 2026-06-26, 15:59): 351.07 USD
- Market cap: 25.80 billion USD (as of 2026-06-26)
- Sector / industry: Health Care / Medical - Dental Supplies
- Index membership: S&P 500
- Next earnings date: not officially scheduled
Disclaimer: This article is for informational purposes only and does not constitute investment advice, a recommendation to buy or sell securities, or a solicitation of any transaction. All data are based on sources believed to be reliable but cannot be guaranteed, and values may have changed since the stated date and time.
